Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2004 1
2005 1
2006 3
2007 3
2008 1
2010 2
2012 2
2013 3
2019 1
2020 1
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Impact and mitigation of abiotic stress in cereals.
Morris PC, Reuveni M, Ortiz R. Morris PC, et al. Front Plant Sci. 2024 Feb 7;15:1374631. doi: 10.3389/fpls.2024.1374631. eCollection 2024. Front Plant Sci. 2024. PMID: 38463571 Free PMC article. No abstract available.
Novel anti-infective compounds from marine bacteria.
Rahman H, Austin B, Mitchell WJ, Morris PC, Jamieson DJ, Adams DR, Spragg AM, Schweizer M. Rahman H, et al. Among authors: morris pc. Mar Drugs. 2010 Mar 5;8(3):498-518. doi: 10.3390/md8030498. Mar Drugs. 2010. PMID: 20411112 Free PMC article. Review.
The Arabidopsis Root Tip (Phospho)Proteomes at Growth-Promoting versus Growth-Repressing Conditions Reveal Novel Root Growth Regulators.
Nikonorova N, Murphy E, Fonseca de Lima CF, Zhu S, van de Cotte B, Vu LD, Balcerowicz D, Li L, Kong X, De Rop G, Beeckman T, Friml J, Vissenberg K, Morris PC, Ding Z, De Smet I. Nikonorova N, et al. Among authors: morris pc. Cells. 2021 Jul 2;10(7):1665. doi: 10.3390/cells10071665. Cells. 2021. PMID: 34359847 Free PMC article.
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.
Rocconi RP, Grosen EA, Ghamande SA, Chan JK, Barve MA, Oh J, Tewari D, Morris PC, Stevens EE, Bottsford-Miller JN, Tang M, Aaron P, Stanbery L, Horvath S, Wallraven G, Bognar E, Manning L, Nemunaitis J, Shanahan D, Slomovitz BM, Herzog TJ, Monk BJ, Coleman RL. Rocconi RP, et al. Among authors: morris pc. Lancet Oncol. 2020 Dec;21(12):1661-1672. doi: 10.1016/S1470-2045(20)30533-7. Lancet Oncol. 2020. PMID: 33271095 Clinical Trial.
22 results